Immuno Concepts, Inc.
Immuno Concepts, Inc. — FDA 510(k) Submissions
Immuno Concepts, Inc. has submitted 36 FDA 510(k) premarket notifications since 1981, of which 36 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Extractable Antinuclear Antibody, Antigen And Control, Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, Test System, Antineutrophil Cytoplasmic Antibodies (anca), Antiserum, Cf, Epstein-barr Virus, Antibody Igm, If, Epstein-barr Virus . Use the specialty filter in the sidebar to narrow results.